Vicunab AB – Medical Alley Association

Vicunab AB

Veravas Announces Novel Rapid Antigen Assay for SARS-CoV-2 Detection in Saliva

Saliva-based, high-throughput rapid antigen assay reportedly detects SARS-CoV-2 with similar sensitivity and specificity as PCR in only 10 minutes. CHARLESTON, S.C. (PRWEB) SEPTEMBER 24, 2020 – Veravas, Inc. an early-stage biotechnology company, has announced the development of its VeraTest™ SARS-CoV-2 Rapid Antigen Assay, based on their patent-pending VeraPrep™ technology and a proprietary novel antibody fragment with […]

Keep your finger on the pulse of Medical Alley from anywhere with the ALLEY NEWSLETTER